India | UK | US

Roche says Tamiflu capacity outstrips demand

Posted : Thu, 26 Apr 2007 19:50:00 GMT
Author : Reuters
Category : US (Business)
News Alerts by Email ( click here )
US Business News | Home
By Sam Cage

BASEL, Switzerland (Reuters) - Swiss-based Roche said on Thursday it was cutting production of influenza drug Tamiflu, seen as one of the best defenses against a possible bird flu pandemic, because supply now exceeds demand.

The pharmaceutical group said it had increased capacity to more than 400 million treatments a year and that supply now significantly outstrips orders with signs of slowing sales to governments wanting to prepare for any outbreak.

The cutback would not affect Roche's expectations for sales of Tamiflu for stockpiling, at between 800 million Swiss francs ($665 million) to 1.2 billion francs in 2007, said William Burns, head of the company's pharmaceuticals unit.

"Our guidance for the year is unchanged," Burns told reporters. "This is not a new signal on the sales outlook for Tamiflu."

Roche said the expansion of capacity meant it could now satisfy "significant additional orders" from governments and companies for Tamiflu.

Roche certificates, its most widely traded form of equity, were 0.8 percent lower at 231.60 francs by 0921 GMT.

The World Health Organization (WHO) and some countries have been stockpiling the drug in case the H5N1 bird flu strain, now mainly affecting poultry, mutates and begins to spread quickly among humans.

Roche will maintain its stock of intermediates and active pharmaceutical ingredients, so it would be ready to gear up to full production capacity if needed.

Sales to governments in the first quarter were slower than in the previous three months and Eugene Tierney, head of specialist sales at Roche's drugs unit, said that was the first indication of a tail off in government orders and demand.

The Basel-based company has so far received orders from governments amounting to about 215 million treatments.


(c) Reuters 2007. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Share/Save/Bookmark

Article : Roche says Tamiflu capacity outstrips demand
Print this article
Email this article

Stay Updated
News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 

 

More US (Business) News click here
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark

 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.